These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25817973)

  • 1. Evaluation of prognostic indicators for canine primary immune-mediated haemolytic anaemia and application of a scoring system for the determination of prognosis.
    Ke SS; Anderson GA; Connolly SL
    Aust Vet J; 2015 Apr; 93(4):93-8. PubMed ID: 25817973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.
    Swann JW; Skelly BJ
    J Small Anim Pract; 2011 Jul; 52(7):353-8. PubMed ID: 21668886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated haemolytic anaemia in 110 dogs in Victoria, Australia.
    McAlees TJ
    Aust Vet J; 2010 Jan; 88(1-2):25-8. PubMed ID: 20148823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary immune-mediated haemolytic anaemia: a retrospective long-term study in 61 dogs.
    Weingart C; Thielemann D; Kohn B
    Aust Vet J; 2019 Dec; 97(12):483-489. PubMed ID: 31454853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
    Al-Ghazlat S
    Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Elwood C; Polton G
    J Vet Intern Med; 2008; 22(5):1075. PubMed ID: 18844828
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of platelet activation in canine immune-mediated haemolytic anaemia.
    Ridyard AE; Shaw DJ; Milne EM
    J Small Anim Pract; 2010 Jun; 51(6):296-304. PubMed ID: 20618628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control study of plasma mean platelet component concentration and survival analysis for dogs with immune-mediated hemolytic anemia.
    Zoia A; Gerou-Ferriani M; Drigo M; Caldin M
    J Am Vet Med Assoc; 2018 Jun; 252(11):1384-1392. PubMed ID: 29772969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990).
    Klag AR; Giger U; Shofer FS
    J Am Vet Med Assoc; 1993 Mar; 202(5):783-8. PubMed ID: 8454517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hemolytic anemia in a dog.
    Avolt MD; Lund JE; Pickett JC
    J Am Vet Med Assoc; 1973 Jan; 162(1):45-6. PubMed ID: 4734241
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia.
    Mellett AM; Nakamura RK; Bianco D
    J Vet Intern Med; 2011; 25(1):71-5. PubMed ID: 21155892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
    Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
    J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prognostic factors and establishment of a prognostic scoring system for canine primary immune-mediated hemolytic anemia.
    Ishihara M; Fujino Y; Setoguchi A; Takahashi M; Nakashima K; Ohno K; Tsujimoto H
    J Vet Med Sci; 2010 Apr; 72(4):465-70. PubMed ID: 20009421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
    Balch A; Mackin A
    Compend Contin Educ Vet; 2007 Apr; 29(4):217-25. PubMed ID: 17726851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of Coombs' test reactivity has diagnostic significance in dogs with immune-mediated haemolytic anaemia.
    Warman SM; Murray JK; Ridyard A; Eastwood J; Silva S; Day MJ
    J Small Anim Pract; 2008 Oct; 49(10):525-30. PubMed ID: 18844824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High intravascular tissue factor expression in dogs with idiopathic immune-mediated haemolytic anaemia.
    Piek CJ; Brinkhof B; Teske E; Rothuizen J; Dekker A; Penning LC
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):346-54. PubMed ID: 21899896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs].
    Oggier D; Tomsa K; Mevissen M; Glaus T
    Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
    Piek CJ; van Spil WE; Junius G; Dekker A
    BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
    Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
    J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.